BACKGROUND: One common public health response to the emergence of HIV has been the provision of sterile syringes to people who inject drugs. In Mexico specialized syringe exchanges are rare, and the sale of needles through pharmacies is often the only way people who inject drugs can obtain sterile syringes. However, people who inject drugs in Tijuana, Mexico report considerable social barriers to successfully purchasing syringes at pharmacies. METHODS: Between October 2008 and March 2009 we conducted seven in-depth focus groups with 47 people who inject drugs in Tijuana, Mexico. Focus group transcripts were analysed using a descriptive and thematic approach rooted in grounded theory. RESULTS: We found that injectors offered a number of explanations for why pharmacies were reluctant to sell them syringes, including fear of police; attitudes toward drug use; fear of stereotypical drug user behaviour such as petty theft, violence, or distressing behaviour; and related fears that an obvious drug using clientèle would drive away other customers. Injectors described a range of ways of attempting to re-frame or negotiate interactions with pharmacy staff so that these and related concerns were ameliorated. These included tactics as simple as borrowing cleaner clothing, through to strategies for becoming 'known' to pharmacy staff as an individual rather than as a member of a stigmatized group. CONCLUSION: Increasing the ability of pharmacy staff and people who inject drugs to successfully negotiate syringe sales are highly desirable. Interventions designed to improve this likelihood need to capitalize on existing solutions developed ad hoc by people who inject drugs and pharmacy staff, and should focus on broadening the range of 'identities' which pharmacy staff are able to accept as legitimate customers. Approaches to achieve this end might include sensitizing pharmacy staff to the needs of people who inject drugs; facilitating individual drug users meeting individual pharmacy staff; and working with drug users to reduce behaviours seen as problematic by pharmacy staff.
BACKGROUND: One common public health response to the emergence of HIV has been the provision of sterile syringes to people who inject drugs. In Mexico specialized syringe exchanges are rare, and the sale of needles through pharmacies is often the only way people who inject drugs can obtain sterile syringes. However, people who inject drugs in Tijuana, Mexico report considerable social barriers to successfully purchasing syringes at pharmacies. METHODS: Between October 2008 and March 2009 we conducted seven in-depth focus groups with 47 people who inject drugs in Tijuana, Mexico. Focus group transcripts were analysed using a descriptive and thematic approach rooted in grounded theory. RESULTS: We found that injectors offered a number of explanations for why pharmacies were reluctant to sell them syringes, including fear of police; attitudes toward drug use; fear of stereotypical drug user behaviour such as petty theft, violence, or distressing behaviour; and related fears that an obvious drug using clientèle would drive away other customers. Injectors described a range of ways of attempting to re-frame or negotiate interactions with pharmacy staff so that these and related concerns were ameliorated. These included tactics as simple as borrowing cleaner clothing, through to strategies for becoming 'known' to pharmacy staff as an individual rather than as a member of a stigmatized group. CONCLUSION: Increasing the ability of pharmacy staff and people who inject drugs to successfully negotiate syringe sales are highly desirable. Interventions designed to improve this likelihood need to capitalize on existing solutions developed ad hoc by people who inject drugs and pharmacy staff, and should focus on broadening the range of 'identities' which pharmacy staff are able to accept as legitimate customers. Approaches to achieve this end might include sensitizing pharmacy staff to the needs of people who inject drugs; facilitating individual drug users meeting individual pharmacy staff; and working with drug users to reduce behaviours seen as problematic by pharmacy staff.
Authors: Wendy Reich; Wilson M Compton; Joe C Horton; Linda B Cottler; Renee M Cunningham-Williams; Robert Booth; Merrill Singer; Carl Leukefeld; Joseph Fink; Tom Stopka; Karen Fortuin Corsi; Michelle Staton Tindall Journal: J Am Pharm Assoc (Wash) Date: 2002 Nov-Dec
Authors: Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: David Goodman-Meza; Maria Elena Medina-Mora; Carlos Magis-Rodríguez; Raphael J Landovitz; Steve Shoptaw; Dan Werb Journal: Am J Public Health Date: 2018-11-29 Impact factor: 9.308
Authors: Pedro Kremer; Miguel Pinedo; Natalie Ferraiolo; Adriana Carolina Vargas-Ojeda; Jose Luis Burgos; Victoria D Ojeda Journal: J Immigr Minor Health Date: 2020-02
Authors: Danielle Horyniak; Karla D Wagner; Richard F Armenta; Jazmine Cuevas-Mota; Erik Hendrickson; Richard S Garfein Journal: Int J Drug Policy Date: 2017-07-03
Authors: Lara K Marquez; Javier A Cepeda; Annick Bórquez; Steffanie A Strathdee; Patricia E Gonzalez-Zúñiga; Clara Fleiz; Claudia Rafful; Richard S Garfein; Susan M Kiene; Stephanie Brodine; Natasha K Martin Journal: Int J Drug Policy Date: 2020-03-09
Authors: Steffanie A Strathdee; Daniela Abramovitz; Remedios Lozada; Gustavo Martinez; Maria Gudelia Rangel; Alicia Vera; Hugo Staines; Carlos Magis-Rodriguez; Thomas L Patterson Journal: PLoS One Date: 2013-06-13 Impact factor: 3.240